Financial Ratios

AMERISE BIOSCIENCES LTD.

NSE : NABSE : 531681ISIN CODE : INE673C01020Industry : Finance - InvestmentHouse : Private
BSE0.620 (0 %)
PREV CLOSE ( ) 0.62
OPEN PRICE ( ) 0.61
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 47344
TODAY'S LOW / HIGH ( )0.61 0.62
52 WK LOW / HIGH ( ) 0.541.15
NSE
This Company is not listed in NSE
Select year
ParticularsMar2022Mar2021Mar2020Mar2019Mar2018
Operational & Financial Ratios
   Earnings Per Share (Rs)0.08-0.05-0.020.000.00
   CEPS(Rs)0.08-0.05-0.020.000.00
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)0.850.770.820.840.84
   Tax Rate(%)0.000.000.000.000.00
Margin Ratios
   Core EBITDA Margin(%)-0.220.35
   EBIT Margin(%)6.100.35
   Pre Tax Margin(%)6.100.35
   PAT Margin (%)6.100.35
   Cash Profit Margin (%)6.100.35
Performance Ratios
   ROA(%)6.23-5.79-2.560.07-0.38
   ROE(%)10.24-6.41-2.710.07-0.38
   ROCE(%)10.17-6.41-2.700.07-0.38
   Asset Turnover(x)1.020.000.000.210.00
   Sales/Fixed Asset(x)
   Working Capital/Sales(x)-242.300.000.000.260.00
Efficiency Ratios
   Fixed Capital/Sales(x)0.000.00
   Receivable days251.891106.76
   Inventory Days0.000.00
   Payable days138.11
Valuation Parameters
   PER(x)16.360.000.000.000.00
   PCE(x)16.36-32.34-36.340.000.00
   Price/Book(x)1.592.141.000.000.00
   Yield(%)0.000.000.00
   EV/Net Sales(x)1.015.58
   EV/Core EBITDA(x)16.48-32.30-36.261602.26-309.66
   EV/EBIT(x)16.48-32.30-36.261602.26-309.66
   EV/CE(x)0.761.930.901.181.17
   M Cap / Sales1.000.00
Growth Ratio
   Net Sales Growth(%)-100.00
   Core EBITDA Growth(%)263.11-126.52-3717.02119.3797.74
   EBIT Growth(%)263.11-126.52-3717.02119.3797.74
   PAT Growth(%)262.90-126.15-3725.15119.3797.74
   EPS Growth(%)262.90-125.78-3866.67118.6797.74
Financial Stability Ratios
   Total Debt/Equity(x)0.010.000.000.000.00
   Current Ratio(x)0.990.040.04180.09109.10
   Quick Ratio(x)0.990.040.04180.09109.10
   Interest Cover(x)1513.01-1631.54-445.17
   Total Debt/Mcap(x)0.010.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.